Patients referred for lung biopsy generally have suspicious intrapulmonary changes, although the exact nature of these changes cannot be determined with certainty until the histological findings are available. In the majority of cases, the lesions are malignant, although inflammatory changes are also possible, for example.
Conditions
Interventions
Group 1: Tract sealing after percutaneous CT-guided lung biopsy using autologous blood patch
Group 2: Tract sealing after percutaneous CT-guided lung biopsy using saline solution
Sponsors
Medizinische Universität Innsbruck
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Male or female persons capable of making decisions Performance of a CT-guided percutaneous lung biopsy Availability of a written declaration of consent
Exclusion criteria
Exclusion criteria: Puncture of > 1 lesion Lesion that is not clearly intrapulmonal Legal incapacity or lack of consent Contraindications to lung biopsy Active pregnancy Participation in another interventional study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurrence of post-interventional pneumothorax within 48 hours after biopsy Verification by means of standardised follow-up examinations (post-interventional low-dose CT scan up to 12 hours after biopsy, follow-up X-ray on the following day) | — |
Secondary
| Measure | Time frame |
|---|---|
| Indication for chest drainage (pneumothorax requiring treatment) Occurrence of other biopsy-related complications Identification of risk factors for the occurrence of post-interventional pneumothorax | — |
Countries
Austria
Contacts
Public ContactElke R. Gizewski
Medizinische Universität Innsbruck, Universitätsklinik für Radiologie
Outcome results
None listed